Pocast Interview with CEO Wayne and Dr Neethling on The New Daily

Anteris CEO Wayne & Dr Neethling have recently conducted a podcast interview with Mr John Elder on the NEWDAILY,

Here is the podcast https://thenewdaily.com.au/podcast/what-does-that-mean-ep-4-podcast/
Starts at the 16:45 mark and ends on the 28:00

Summary:

1) SAVR usually lasts around 20 years
2) TAVR usually last around 3 - 5 years
3) Average for TAVR patients now is 73 years old down from 83 years old
4) There is a huge need for a durable Valve
5) Explanation of the process involved in making the Adapt tissue ( Dr Neethling)
6) Market projection for TAVE to reack 10 Billion within couple years
7) AVR Valve (potentially) is the cure for Aortic stenosis
8) The Adapt Tissue is a game changer as it addresses the rejection of foreign tissue and the issue of calcification.

DYOR
Barra